Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03640507 · ClinicalTrials.gov registry record · Phase 2
Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT03640507 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 30 participants.
The verdict
NCT03640507, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.
Interventions
- DRUG Sterile saline
- DRUG Chlorhexidine-alcohol
- DRUG Povidine-iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-06-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03640507
The ClinicalTrials.gov registry entry for NCT03640507 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sterile saline is the first listed.
NCT03640507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03640507 about?
NCT03640507 is a clinical study titled "Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline". The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with salin...
What is the current status of trial NCT03640507?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2018-10-01. Estimated completion is 2019-06-14.
What interventions are being tested in trial NCT03640507?
The interventions under investigation include: Sterile saline (DRUG), Chlorhexidine-alcohol (DRUG), Povidine-iodine (DRUG).
Who is sponsoring clinical trial NCT03640507?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.